Alexis Boaz is an Associate in the Health Care and Life Sciences practice, in the Washington, DC, office of Epstein Becker Green. She will be focusing her practice on fraud and abuse, transactional, regulatory, and compliance matters.
Ms. Boaz received her Juris Doctor from The George Washington University Law School (“GW”), where she was a student attorney for the Health Insurance Counseling Project and a recipient of the President’s Volunteer Service Award and GW Excellence in Service Award in recognition of her pro bono work. She also earned a Master of Public Health in Health Policy from The George Washington University – Milken Institute School of Public Health.
During law school, Ms. Boaz interned at various divisions of the U.S. Department of Health and Human Services (“HHS”), including the Office of General Counsel’s Public Health Division and Centers for Medicare & Medicaid Services Division and the Office of Global Affairs’ Division for Trade and Health. She also served as a Health Policy Law Clerk for the U.S. Senate Committee on Finance; as a Health Policy Intern for a public policy think-tank; as a Health Policy Fellow for the Congressional Black Caucus Foundation Health Braintrust; and as a Legal Intern at the White House (in the Executive Office of the President).
Before attending law school, Ms. Boaz earned a Bachelor of Science in Health Care Management and Policy from Georgetown University’s School of Nursing & Health Studies. She also participated in health care-related internships at the HHS Office of Inspector General’s Office of Evaluations and Inspections; the U.S. Senate Committee on Health, Education, Labor & Pensions; a nonprofit, academic health system in Tennessee; the DC Department of Health’s HIV/AIDS, Hepatitis, STD, and TB Administration (“HAHSTA”); an academic teaching hospital in DC; and a national nonprofit public health charitable organization focused on fetal alcohol syndrome.
More Legal and Business Bylines From Alexis Boaz
- CMS Forwards Its Health Equity Agenda through Its Annual Prospective Payment System Rulemaking Process - (Posted On Tuesday, May 02, 2023)
- Comments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 2023 - (Posted On Tuesday, March 07, 2023)
- 2023 Health Policy Outlook – Diagnosing Health Care [PODCAST] - (Posted On Thursday, January 12, 2023)
- Federal District Court Vacates QPA Rebuttable Presumption Provisions of No Surprises Act Regulations - (Posted On Monday, February 28, 2022)
- CMS Releases No Surprises Act State Enforcement Letters - (Posted On Tuesday, February 15, 2022)
- Podcast: No Surprises Act: New Rules and Guidance for Stakeholders (Part 2) – Diagnosing Health Care - (Posted On Thursday, January 13, 2022)
- No Surprises Act: New Rules and Guidance for Stakeholders (Part 1) – Diagnosing Health Care [VIDEO] - (Posted On Thursday, December 09, 2021)
- Getting Ready for the No Surprises Act [VIDEO] - (Posted On Tuesday, November 23, 2021)
- Diagnosing Health Care - No Surprises Act: Considerations for Plans and Providers [PODCAST] - (Posted On Thursday, September 30, 2021)
- False Claims Act Enforcement During the COVID-19 Pandemic and Beyond - (Posted On Friday, August 28, 2020)